MicroRNAs: Turning the Tide in Testicular Cancer

Nirmish Singla; John T. Lafin; Aditya Bagrodia

doi:10.1016/j.eururo.2019.06.010

MicroRNAs: Turning the Tide in Testicular Cancer

Nirmish Singla, John T. Lafin, Aditya Bagrodia

Research output: Contribution to journal › Editorial › peer-review

22 Scopus citations

Abstract

MicroRNAs are poised to radically change the way we care for patients with germ cell tumors (GCTs) across all disease states, from diagnosis to managing chemorefractory disease. miR-371a-3p is a promising candidate biomarker that may precisely individualize GCT treatment paradigms.

Original language	English (US)
Pages (from-to)	541-542
Number of pages	2
Journal	European urology
Volume	76
Issue number	5
DOIs	https://doi.org/10.1016/j.eururo.2019.06.010
State	Published - Nov 2019

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.eururo.2019.06.010

Cite this

@article{0aeb6de2e9bd46b6a702dc0296dda478,

title = "MicroRNAs: Turning the Tide in Testicular Cancer",

abstract = "MicroRNAs are poised to radically change the way we care for patients with germ cell tumors (GCTs) across all disease states, from diagnosis to managing chemorefractory disease. miR-371a-3p is a promising candidate biomarker that may precisely individualize GCT treatment paradigms.",

author = "Nirmish Singla and Lafin, {John T.} and Aditya Bagrodia",

note = "Publisher Copyright: {\textcopyright} 2019 European Association of Urology",

year = "2019",

month = nov,

doi = "10.1016/j.eururo.2019.06.010",

language = "English (US)",

volume = "76",

pages = "541--542",

journal = "European urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "5",

}

TY - JOUR

T1 - MicroRNAs

T2 - Turning the Tide in Testicular Cancer

AU - Singla, Nirmish

AU - Lafin, John T.

AU - Bagrodia, Aditya

PY - 2019/11

Y1 - 2019/11

N2 - MicroRNAs are poised to radically change the way we care for patients with germ cell tumors (GCTs) across all disease states, from diagnosis to managing chemorefractory disease. miR-371a-3p is a promising candidate biomarker that may precisely individualize GCT treatment paradigms.

AB - MicroRNAs are poised to radically change the way we care for patients with germ cell tumors (GCTs) across all disease states, from diagnosis to managing chemorefractory disease. miR-371a-3p is a promising candidate biomarker that may precisely individualize GCT treatment paradigms.

UR - http://www.scopus.com/inward/record.url?scp=85067344317&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067344317&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2019.06.010

DO - 10.1016/j.eururo.2019.06.010

M3 - Editorial

C2 - 31230742

AN - SCOPUS:85067344317

SN - 0302-2838

VL - 76

SP - 541

EP - 542

JO - European urology

JF - European urology

IS - 5

ER -

MicroRNAs: Turning the Tide in Testicular Cancer

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this